- Home
- SUNS vs THTX Comparison
SUNS vs THTX Comparison
Compare SUNS & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNS
- THTX
- Stock Information
- Founded
- SUNS 2023
- THTX 1993
- Country
- SUNS United States
- THTX Canada
- Employees
- SUNS N/A
- THTX N/A
- Industry
- SUNS Real Estate Investment Trusts
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- SUNS Real Estate
- THTX Health Care
- Exchange
- SUNS Nasdaq
- THTX Nasdaq
- Market Cap
- SUNS 142.3M
- THTX 144.8M
- IPO Year
- SUNS N/A
- THTX N/A
- Fundamental
- Price
- SUNS $10.48
- THTX $3.17
- Analyst Decision
- SUNS Strong Buy
- THTX Hold
- Analyst Count
- SUNS 3
- THTX 1
- Target Price
- SUNS $13.67
- THTX N/A
- AVG Volume (30 Days)
- SUNS 63.8K
- THTX 1.1M
- Earning Date
- SUNS 08-07-2025
- THTX 07-09-2025
- Dividend Yield
- SUNS 11.45%
- THTX N/A
- EPS Growth
- SUNS N/A
- THTX N/A
- EPS
- SUNS 1.02
- THTX N/A
- Revenue
- SUNS $13,066,680.00
- THTX $84,378,000.00
- Revenue This Year
- SUNS $148.89
- THTX N/A
- Revenue Next Year
- SUNS $43.47
- THTX $15.13
- P/E Ratio
- SUNS $10.28
- THTX N/A
- Revenue Growth
- SUNS 1342.10
- THTX 2.19
- 52 Week Low
- SUNS $7.80
- THTX $1.12
- 52 Week High
- SUNS $15.74
- THTX $3.20
- Technical
- Relative Strength Index (RSI)
- SUNS N/A
- THTX 72.50
- Support Level
- SUNS N/A
- THTX $2.28
- Resistance Level
- SUNS N/A
- THTX $3.20
- Average True Range (ATR)
- SUNS 0.00
- THTX 0.02
- MACD
- SUNS 0.00
- THTX -0.00
- Stochastic Oscillator
- SUNS 0.00
- THTX 100.00
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.